Spirecut secures fresh funding and enters new markets

Headquartered in Muttenz (Basel-Landschaft), Spirecut specializes in non-invasive surgical instruments for hand surgery. Their patented devices, known as Sono-Instruments, utilize ultrasound guidance for procedures related to carpal tunnel syndrome and trigger finger. These conditions commonly affect women and individuals with underlying health issues, including diabetes mellitus and people that perform repetitive hand movements. The Sono-Instrument, as thin as a needle, allows medical professionals to safely section the ligament beneath the skin. This approach is less invasive than traditional surgery, with the entire process taking just a few minutes. Notably, the device is FDA registered and has obtained the CE-Mark.

Results from a recent publication, “Retrograde Percutaneous Release of Trigger Finger or Thumb Using Sono-Instruments®: Detailed Technique, Pearls, and Pitfalls”, underscore the role of Sono-Instruments as a cutting-edge, minimally invasive solution for stenosing tenosynovitis or trigger finger. The study highlights the instruments' capacity for quick patient recovery, the ability to treat multiple conditions concurrently, and minimal patient discomfort, facilitating a swift return to daily activities.

Sono-Instruments are currently used by surgeons in Belgium, Switzerland, and the United Kingdom. Building on this growing customer demand, Spirecut plans to enter the United States, Portugal, and Italy in the forthcoming months, thereby broadening its impact in hand surgery. In line with this growth strategy, Spirecut has established distribution agreements with Bimar Ortho s.r.l. in Italy and Pagaimo Medical in Portugal, enhancing its presence in Europe. These partnerships extend the accessibility of Spirecut's Sono-Instruments® to new regions, further solidifying the company's commitment to expanding its European distribution network alongside existing operations in the United Kingdom, where Sovereign Medical Group is responsible for distribution in addition to Ireland, Canada and the United States. The proceeds from its series A financing round with private investors provides additional resources to fast-track the startup’s plans.

(RAN)